Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

References for PMC Articles for PubMed (Select 22544628)

1.

Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand.

Pike JW.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):3-10. doi: 10.1016/j.mce.2011.05.012. Epub 2011 Jun 1. Review.

2.

Vitamin D metabolism within bone cells: effects on bone structure and strength.

Anderson PH, Atkins GJ, Turner AG, Kogawa M, Findlay DM, Morris HA.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):42-7. doi: 10.1016/j.mce.2011.05.024. Epub 2011 Jun 1. Review.

PMID:
21664230
3.

Vitamin D: an ancient hormone.

Bikle DD.

Exp Dermatol. 2011 Jan;20(1):7-13. Review.

PMID:
21197695
4.

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA.

J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704. Epub 2010 Nov 29.

5.

Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts.

Chen J, Olivares-Navarrete R, Wang Y, Herman TR, Boyan BD, Schwartz Z.

J Biol Chem. 2010 Nov 19;285(47):37041-50. doi: 10.1074/jbc.M110.157115. Epub 2010 Sep 15.

6.

Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.

Kogawa M, Findlay DM, Anderson PH, Ormsby R, Vincent C, Morris HA, Atkins GJ.

Endocrinology. 2010 Oct;151(10):4613-25. doi: 10.1210/en.2010-0334. Epub 2010 Aug 25.

PMID:
20739402
7.

Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57.

Nemere I, Garbi N, Hämmerling GJ, Khanal RC.

J Biol Chem. 2010 Oct 8;285(41):31859-66. doi: 10.1074/jbc.M110.116954. Epub 2010 Aug 3.

8.

The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.

Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):277-80. doi: 10.1016/j.jsbmb.2010.03.048. Epub 2010 Mar 19.

PMID:
20304055
9.

Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development.

Naja RP, Dardenne O, Arabian A, St Arnaud R.

Endocrinology. 2009 Sep;150(9):4024-32. doi: 10.1210/en.2008-1410. Epub 2009 May 28.

PMID:
19477943
10.

Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men.

Ensrud KE, Taylor BC, Paudel ML, Cauley JA, Cawthon PM, Cummings SR, Fink HA, Barrett-Connor E, Zmuda JM, Shikany JM, Orwoll ES; Osteoporotic Fractures in Men Study Group.

J Clin Endocrinol Metab. 2009 Aug;94(8):2773-80. doi: 10.1210/jc.2008-2786. Epub 2009 May 19.

11.

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

Avenell A, Gillespie WJ, Gillespie LD, O'Connell D.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227. doi: 10.1002/14651858.CD000227.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD000227.

PMID:
19370554
12.

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials.

Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J.

Arch Intern Med. 2009 Mar 23;169(6):551-61. doi: 10.1001/archinternmed.2008.600. Review.

PMID:
19307517
13.

Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice.

Xue Y, Fleet JC.

Gastroenterology. 2009 Apr;136(4):1317-27, e1-2. doi: 10.1053/j.gastro.2008.12.051. Epub 2008 Dec 27.

14.

Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults.

Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, Dietrich T, Willett WC.

J Bone Miner Res. 2009 May;24(5):935-42. doi: 10.1359/jbmr.081242.

15.

Vitamin D deficiency.

Holick MF.

N Engl J Med. 2007 Jul 19;357(3):266-81. Review. No abstract available.

PMID:
17634462
16.

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD, Morris HA.

Bone. 2007 Jun;40(6):1517-28. Epub 2007 Mar 2.

PMID:
17395559
17.

RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells.

Anderson PH, Atkins GJ, Findlay DM, Oloughlin PD, Welldon K, Vincent C, Morris HA.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):601-5. Epub 2006 Dec 22.

PMID:
17254772
18.

Risk assessment for vitamin D.

Hathcock JN, Shao A, Vieth R, Heaney R.

Am J Clin Nutr. 2007 Jan;85(1):6-18. Review.

19.

Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.

Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G.

J Clin Invest. 2006 Dec;116(12):3150-9. Epub 2006 Nov 9.

20.

Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells.

van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP.

FASEB J. 2006 Nov;20(13):2417-9. Epub 2006 Oct 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk